Self-Swab COVID-19 Collection Kit Receives FDA EUA for Use by CLIA-Certified Laboratories
The Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to a new COVID-19 self-collection kit, enabling public health and large private labs to increase access to testing. More...17 Sep 2020
First-in-Class Rapid Diagnostic Test Measures COVID-19 Neutralizing Antibodies in Plasma and Serum
A new rapid diagnostic test is expected to be the market’s first COVID-19 rapid diagnostic test for measuring the levels of functional SARS-CoV-2 neutralizing antibodies in a lateral flow assay format. More...17 Sep 2020
Gold Member
Hematology Analyzer
Medonic M32B
8-Channel Pipette
SAPPHIRE 20–300 µL
Hemodynamic System Monitor
OptoMonitor
In Other News
Siemens Collaborates with CDC to Develop Process for Standardizing SARS-CoV-2 Assays
Global Swab and Viral Transport Medium Market Growing Rapidly Due to Rising Demand from COVID-19 Pandemic
Universal COVID-19 Antibody Test Could Identify Suitable Plasma Donors and Provide Critical Information on Coronavirus Immunity
Microbiologics Launches IVD Process Controls and Inactivated Whole Virus Controls for SARS-CoV-2 Testing
New Ultra-Sensitive Super Antibody Test Could Identify COVID-19 Patients at Risk for Severe Illness
DiaSorin Receives FDA Clearance for Simplexa Test That Differentiates Between COVID-19, Flu and RSV
QIAGEN to Launch Rapid Portable COVID-19 Test That Can Analyze Over 30 Samples per Hour for SARS-CoV-2 Antigen
Avacta Launches High Performance Affimer-Based SARS-CoV-2 ELISA Laboratory Test
Korea’s Sugentech Granted FDA EUA for Gold Nanoparticle-Based Immunochromatographic COVID-19 Test
First-Ever Commercially Available COVID-19 Seroconversion Panel to Confirm Presence of Anti-SARS-CoV-2 Antibodies Completed
Stool Test Could Better Detect COVID-19 than Traditional Nose Swabs Due to Prolonged Gut Viral Infection
Groundbreaking RNA Extraction-Free qSanger-COVID-19 Assay Secures FDA EUA
COVID-19 Test Kit Using Portable Technology with Mobile App Result Reporting Secures FDA EUA
Oversensitive COVID-19 Tests Detecting Dead Coronavirus Cells, Driving False Positives and Reinfections
Roche Receives FDA EUA for Cobas SARS-CoV-2 & Influenza A/B Test for Use on Cobas 6800/8800 Systems
NIH Offers USD 129.3 Million in Scale-Up and Manufacturing Support for New Set of COVID-19 Testing Technologies
New Promega XpressAmp Direct Amplification Reagents Allow COVID-19 Testing Labs to Skip RNA Extraction
MicroGEM Awarded Over USD 40 Million by NIH to Fast-Track Rapid, No-Lab COVID-19 Saliva Test
Combining PCR and Antibody Tests at POC Dramatically Increases COVID-19 Detection in Hospitalized Patients
ThermoGenesis Launches Comprehensive Suite of COVID-19 Products and Services to Better Detect, Track and Fight Novel Coronavirus
Roche to Launch 15-Minute COVID-19 Rapid Antigen Test in Europe and File for EUA in US
New Portable, 30-Minute COVID-19 Test Could Enable Diagnosis at POC Without Need for Laboratory
Nasopharyngeal and Oropharyngeal Swabs Detect More COVID-19 Cases than Saliva Testing in New Study
